Determinants Of Pregnant Women's Awareness of Intermittent Malaria Prevention Treatment in Kano, Nigeria

Abstract

Introduction: In Sub-Saharan Africa, malaria continues to pose a major risk to pregnancy. Numerous issues are linked to it, including low birth weight, abortion, preterm delivery, stillbirth, mother and newborn mortality, and maternal anaemia. This study investigated pregnant women's awareness of and factors influencing their usage of intermittent preventive therapy for malaria in Karkasara Tarauni L.G.A., Kano State. The specific goal is to determine how much pregnant women know about intermittent preventive medication for malaria.

Method: This study employed a descriptive cross-sectional approach. Tarauni LGA, Kano State, pregnant women made up the study population. A pretested, structured, self-administered questionnaire was used to collect data. After being handed to the responders in the ward, the surveys were promptly picked up. IBM Statistical Package for Social Sciences Software (SPSS) version 20 was used to analyze the data at the univariate, bivariate, and multivariate levels. Results: 347 of the 370 respondents who were contacted consented to be interviewed, yielding a 93.8% response rate. According to the survey, 60.81% of respondents were unaware that there is a medication to prevent malaria infection during pregnancy, whereas 39.19% of respondents were. Additionally, 3.7% of respondents had never heard of FANSIDER, compared to 96.3% who had. Furthermore, 61.7% of the respondents did not get a lesson on mIPTp during ANC visits, whereas 38.3% did.

Conclusion:

The study's conclusions showed that 72.0%, 39.2%, 96.3%, and 99.7% of pregnant women were aware that using an ANC, using medication to prevent malaria infection during pregnancy, and using FANSIDAR and LLITNs do prevent malaria during pregnancy, respectively.

The study also found that the expenses of Fansider and its adverse effects were not the main obstacles preventing pregnant women in the study area from using IPT-Sp.

Keywords:

References

Azizi SC. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: An analysis of demographic and health survey 2015-2016. BMC Public Health. 2020;20(1):1–12.

Dahiru Balami A, Said SM, Afiah N, Zulkefli M, Baru PA. A review on factors influencing the adoption of Malaria preventive practices among pregnant women in sub-Saharan Africa. J Adv Rev Sci Res J Adv Rev Sci Res J J Adv Rev Sci Res [Internet]. 2016;28(1):25–32. Available from: www.akademiabaru.com/arsr.html

Roman E, Andrejko K, Wolf K, Henry M, Youll S, Florey L, et al. Determinants of uptake of intermittent preventive treatment during pregnancy: a review. Malar J [Internet]. 2019;18(1):1–9. Available from: https://doi.org/10.1186/s12936-019-3004-7

Ibrahim H, Maya ET, Issah K, Apanga PA, Bachan EG, Noora CL. Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in sunyani municipality, Ghana. Pan Afr Med J. 2017;28:1–12.

Nkunzimana E, Sufiyan Babale M. Knowledge and Utilization of Intermittent Preventive Treatment of Malaria among Pregnant Women in Muramvya Health District, Burundi, 2018. East African Heal Res J. 2020;4(1):81–91.

Mbonye AK, Birungi J, Yanow SK, Shokoples S, Malamba S, Alifrangis M, et al. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for Malaria in Uganda. Antimicrob Agents Chemother. 2015;59(9):5475–82.

Peters GO, Naidoo M. Factors influencing the use of intermittent preventive treatment of pregnant women seeking care at primary healthcare facilities in the bwari area council, Abuja, Nigeria. African J Prim Heal Care Fam Med. 2020;12(1):1–8.

Bello OO, Oni O. Health Workers’ Awareness and Knowledge of Current Recommendation of Intermittent Preventive Treatment in Pregnancy in South-Western Nigeria. Ethiop J Health Sci. 2020;30(1):125–34.

Odongo CO, Bisaso KR, Kitutu F, Obua C, Byamugisha J. Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women. Malar J. 2015;14(1):1–8.

Oladimeji KE, Tsoka-Gwegweni JM, Ojewole E, Yunga ST. Knowledge of malaria prevention among pregnant women and non-pregnant mothers of children aged under 5 years in Ibadan, South West Nigeria. Malar J [Internet]. 2019;18(1):1–12. Available from: https://doi.org/10.1186/s12936-019-2706-1.

Emmanuel Ayila A. Statistical Analysis of Urban Growth in Kano Metropolis, Nigeria. Int J Environ Monit Anal. 2014;2(1):50.

Okethwangu D, Opigo J, Atugonza S, Kizza CT, Nabatanzi M, Biribawa C, et al. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: Analysis of data from the Uganda Demographic and Health Survey, 2016. Malar J [Internet]. 2019;18(1):1–8. Available from: https://doi.org/10.1186/s12936-019-2883-y

Akinleye SO, Falade CO, Ajayi IO. Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study. BMC Pregnancy Childbirth. 2009;9:28.

Mutagonda R, Kamuhabwa AAR, Massawe S, Mpembeni R. Intermittent preventive therapy and treatment of malaria during pregnancy: A study of knowledge among pregnant women in Rufiji District, Southern Tanzania. Trop J Pharm Res. 2012;11(5):835–45.